Regeneron declines to make higher bid for 23andMe after Wojcicki’s $305 million offer
-Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning bid of ...
Read moreDetailsTag: company spokesperson
OpenAI Eyeing More Data Centers in Texas, Other States for Stargate
(Bloomberg) -- A joint venture from OpenAI, SoftBank Group Corp. and Oracle Corp. is close to selecting additional sites for ...
Read moreDetails
